Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CRISPR THERAPEUTICS AG
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 148,901 shares of CRSP (CRISPR THERAPEUTICS AG), worth $7.8M as of 2025-Q4. This is a new position. CRSP represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$7.8M
Current Shares
148,901
Total Value Change
-$29.7M
Total Shares Change
-545,057
Other major holders of CRSP: CAPITAL FUND MANAGEMENT S.A., BNP PARIBAS FINANCIAL MARKETS
New |
| 148,901 |
- |
| $7.8M |
| 0.0% |
| $53.19 |
38 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $63.77 | 0 |
| 2025-Q2 | Decreased | 964,690 | -50.6% | $46.9M | 0.0% | $47.49 | 0 |
| 2025-Q1 | Increased | 2M | +182.9% | $66.5M | 0.0% | $36.99 | 48 |
| 2024-Q4 | Increased | 690,191 | +2.0% | $27.2M | 0.0% | $38.65 | 29 |
| 2024-Q3 | Decreased | 676,326 | -2.5% | $31.8M | 0.0% | $47.32 | 0 |
| 2024-Q2 | Increased | 693,958 | +528.2% | $37.5M | 0.0% | $54.01 | 47 |